Publications

Sort by: Author [ Title  (Asc)] Type Year
A B C D E F G H I J K L [M] N O P Q R S T U V W X Y Z   [Show ALL]
M
Larguinho, Miguel, Ana Cordeiro, Mario S. Diniz, Pedro M. Costa, and Pedro V. Baptista. "Metabolic and histopathological alterations in the marine bivalve Mytilus galloprovincialis induced by chronic exposure to acrylamide." Environmental Research 135 (2014): 55-62. Abstract

n/a

Veigas, B., E. Fortunato, and P. V. Baptista. "Mobile based gold nanoprobe TB diagnostics for point-of-need." Methods in molecular biology (Clifton, N.J.) 1256 (2015): 41-56. Abstract

n/a

Conde, João, Pedro V. Baptista, Yulan Hernández, Vanesa Sanz, and Jesus M. de la Fuente. "Modification of plasmid DNA topology by ‘histone-mimetic’ gold nanoparticles." Nanomedicine (2012).
Vinhas, Raquel, Alexandra R. Fernandes, and Pedro V. Baptista. "Molecular Diagnostics of Chronic Myeloid Leukemia - precision medicine via gold nanoparticles." In In CDx and precision medicine for hematologic malignancies, edited by Il-Jin Kim, 205-230. PanStanford Publishing, 2018.
Sanz, Vanesa, Joao Conde, Alfredo Ambrosone, Yulan Hernandez, Valentina Marchesasno, Giovani G. Estrada, Manuel R. Ibarra, Pedro V. Baptista, Furong Tian, Claudia Tortiglione, and Jesus M. de la Fuente. "Multifunctional gold nanoparticles for gene silencing." Abstracts of Papers of the American Chemical Society 243 (2012). Abstract

n/a

Fernandes, Alexandra R., Joao Jesus, Pedro Martins, Sara Figueiredo, Daniela Rosa, Luisa M. R. D. R. S. Martins, Maria Luisa Corvo, Manuela C. Carvalheiro, Pedro M. Costa, and Pedro V. Baptista. "Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents." Journal of Controlled Release 245 (2017): 52-61. Abstract

n/a

Alves, Pedro Urbano, Raquel Vinhas, Alexandra R. Fernandes, Semra Zuhal Birol, Levent Trabzon, Iwona Bernacka-Wojcik, Rui Igreja, Paulo Lopes, Pedro Viana Baptista, Hugo Águas, Elvira Fortunato, and Rodrigo Martins. "Multifunctional microfluidic chip for optical nanoprobe based RNA detection – application to Chronic Myeloid Leukemia." Scientific Reports 8 (2018): 381. AbstractWebsite

Many diseases have their treatment options narrowed and end up being fatal if detected during later stages. As a consequence, point-of-care devices have an increasing importance for routine screening applications in the health sector due to their portability, fast analyses and decreased cost. For that purpose, a multifunctional chip was developed and tested using gold nanoprobes to perform RNA optical detection inside a microfluidic chip without the need of molecular amplification steps. As a proof-of-concept, this device was used for the rapid detection of chronic myeloid leukemia, a hemato-oncological disease that would benefit from early stage diagnostics and screening tests. The chip passively mixed target RNA from samples, gold nanoprobes and saline solution to infer a result from their final colorimetric properties. An optical fiber network was used to evaluate its transmitted spectra inside the chip. Trials provided accurate output results within 3 min, yielding signal-to-noise ratios up to 9 dB. When compared to actual state-of-art screening techniques of chronic myeloid leukemia, these results were, at microscale, at least 10 times faster than the reported detection methods for chronic myeloid leukemia. Concerning point-of-care applications, this work paves the way for other new and more complex versions of optical based genosensors.

Giestas, Letícia, Guilherme N. M. Ferreira, Pedro V. Baptista, and João Carlos Lima. "Multiplexed spectral coding for simultaneous detection of DNA hybridization reactions based on FRET." Sens. Actuator B-Chem. 134 (2008): 146-157.